Have clinical data reported any effects of Contour Fit injections on subcutaneous tissue fibrosis, changes in blood and lymphatic flow, or systemic metabolism (blood fatty acids and liver enzyme levels), in addition to fat cell reduction?

If evidence exists at the clinical trial or case level, how have the associations between injection dosage, treatment interval, and safety been confirmed?

To what extent are long-term follow-up results secured regarding the risk of tissue degeneration and fat redistribution upon repetition?